A cross-sectional analysis of out-of-pocket expenses for people living with a cancer in rural and outer metropolitan Western Australia
Neli S. Slavova-Azmanova A G , Jade C. Newton
A , Claire E. Johnson A B C , Harry Hohnen A , Angela Ives A , Sandy McKiernan D , Violet Platt E , Max Bulsara F and Christobel Saunders A
A UWA Medical School, The University of Western Australia, 35 Stirling Highway, Perth, WA 6099, Australia. Email: jadecnewton@gmail.com; harry.hohnen@uwa.edu.au; angela.ives@uwa.edu.au; christobel.saunders@uwa.edu.au
B School of Nursing and Midwifery, Monash University, Wellington Road, Clayton, Vic. 3800, Australia.
C Eastern Health, 5 Arnold Street, Box Hill, Vic. 3128, Australia. Email: claire_johnson@uow.edu.au
D Cancer Council Western Australia, Perth, WA 6008, Australia. Email: sandy.mckiernan@svdpwa.org.au
E WA Cancer and Palliative Care Network, North Metropolitan Health Service, 4th Floor A Block, Verdun Street, Nedlands, WA 6009, Australia. Email: violetxplatt@hotmail.com
F Institute for Health Research, University of Notre Dame, 32 Mouat Street, Fremantle, WA 6959, Australia. Email: max.bulsara@nd.edu.au
G Corresponding author. Email: neli.slavova-azmanova@uwa.edu.au
Australian Health Review 45(2) 148-156 https://doi.org/10.1071/AH19265
Submitted: 29 November 2019 Accepted: 15 June 2020 Published: 16 February 2021
Abstract
Objective To determine the extent of medical and non-medical out-of-pocket expenses (OOPE) among regional/rural and outer metropolitan Western Australian patients diagnosed with cancer, and the factors associated with higher costs.
Methods Cross-sectional data were collected from adult patients living in four regional/rural areas and two outer metropolitan regions in Western Australia who had been diagnosed with breast, prostate, colorectal or lung cancer. Consenting participants were mailed demographic and financial questionnaires, and requested to report all OOPE related to their cancer treatment.
Results The median total OOPE reported by 308 regional/rural participants and 119 outer metropolitan participants were A$1518 (interquartile range (IQR): A$581–A$3769) and A$2855 (IQR: A$958–A$7142) respectively. Participants most likely to experience higher total OOPE were younger than 65 years of age, male, resided in the outer metropolitan area, worked prior to diagnosis, had private health insurance, were in a relationship, and underwent surgery. Multivariate analysis of regional/rural participants revealed that receiving care at a rural cancer centre was associated with significantly lower non-medical OOPE (estimated mean A$805, 95% confidence interval (CI): A$735–A$875, P = 0.038; compared with other rural participants (A$1347, 95% CI: A$743–A$1951, P < 0.001)).
Conclusion The cancer patients who participated in this study experienced variation in OOPE, with outer metropolitan participants reporting higher OOPE compared with their regional/rural counterparts. There is a need for cost transparency and access to care close to home, so that patients can make informed choices about where to receive their care.
What is known about the topic? In recent years, OOPE for health care in general and cancer in particular have been widely debated by consumers and not-for-profit organisations; the topic has attracted much political attention because it affects both equity and access to care and has wider financial implications for the community. Research studies and reports from both consumer organisations and a Ministerial Advisory Committee found that cancer patients can face exorbitant out-of-pocket costs, and that individuals with private health insurance and those with prostate and breast cancer reported higher costs. In Western Australia, a cancer centre providing comprehensive cancer care was established in the second most populous region to ameliorate the high costs for travel and accommodation that regional cancer patients are known to experience.
What does this paper add? This study is unique because it collected detailed cost information from patients and reports on the OOPE of regional/rural and outer metropolitan Western Australian patients receiving care for one of the four most common cancers; it therefore offers novel insight into the experiences of these groups. This study demonstrates that outer metropolitan cancer patients are experiencing much higher OOPE compared with regional/rural cancer patients. Additionally, regional/rural study participants who accessed a Regional Cancer Centre experienced significantly lower non-medical OOPE, compared with regional/rural study participants receiving care elsewhere.
What are the implications for practitioners? First, there is a need for improved communication of OOPE to minimise costs to the patient, for example, by facilitating access to local cancer care. Health service providers and insurance companies can improve cost transparency for cancer patients by making this information more readily available, allowing patients to make informed financial choices about where to seek care. Second, the needs of working patients deserve specific attention. These patients face significant work uncertainty and additional distress following a cancer diagnosis.
Keywords: breast cancer, cancer, cancer treatment, colorectal cancer, cross-sectional study, financial toxicity, health expenditure, lung cancer, outer metropolitan, out-of-pocket costs, out-of-pocket expenditure, prostate cancer, regional, rural, Western Australia.
References
[1] Consumers Health Forum of Australia. Out of pocket pain research report. 2018. Available at: https://chf.org.au/sites/default/files/20180404_oop_report.pdf [verfied 10 October 2020].[2] Breast Cancer Network Australia. Breast Cancer Network Australia’s state of the nation report. 2018. Available at: https://www.bcna.org.au/media/6656/sotn-report-lowres.pdf [verified 10 October 2020].
[3] Newton JC, Johnson CE, Hohnen H, Bulsara M, Ives A, McKiernan S, Platt V, McConigley R, Slavova-Azmanova NS, Saunders C. Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer. Support Care Cancer 2018; 26 3543–52.
| Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer.Crossref | GoogleScholarGoogle Scholar | 29704109PubMed |
[4] Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Patient out-of-pocket medical expenses over 2 years among Queenslanders with and without a major cancer. Aust J Prim Health 2018; 24 530–6.
| Patient out-of-pocket medical expenses over 2 years among Queenslanders with and without a major cancer.Crossref | GoogleScholarGoogle Scholar | 30463662PubMed |
[5] Ó Céilleachair A, Hanly P, Skally M, O’Leary E, O’Neill C, Fitzpatrick P, Kapur K, Staines A, Sharp L. Counting the cost of cancer: out-of-pocket payments made by colorectal cancer survivors. Support Care Cancer 2017; 25 2733–41.
| Counting the cost of cancer: out-of-pocket payments made by colorectal cancer survivors.Crossref | GoogleScholarGoogle Scholar | 28341973PubMed |
[6] Gordon LG, Walker SM, Mervin MC, Lowe A, Smith DP, Gardiner RA, Chambers SK. Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. Eur J Cancer Care 2017; 26 e12392
| Financial toxicity: a potential side effect of prostate cancer treatment among Australian men.Crossref | GoogleScholarGoogle Scholar |
[7] Mahal A, Karan A, Fan VY, Engelgau M. The economic burden of cancers on Indian households. PLoS One 2013; 8 e71853
| The economic burden of cancers on Indian households.Crossref | GoogleScholarGoogle Scholar | 23951258PubMed |
[8] Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, Tai MH, Ke X, Stuart B. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer 2013; 119 1257–65.
| Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.Crossref | GoogleScholarGoogle Scholar | 23225522PubMed |
[9] Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Out-of-pocket medical expenses for Queenslanders with a major cancer. Med J Aust 2018; 208 497–497.
| Out-of-pocket medical expenses for Queenslanders with a major cancer.Crossref | GoogleScholarGoogle Scholar | 29902395PubMed |
[10] Uceda-Torres ME, Rodríguez-Rodríguez JN, Alvarado-Gómez F, Sánchez-Ramos JL, McGrath P. Informal caregivers of palliative oncohematologic patients: the invisible guests: an exhaustive review of the literature available. Am J Hosp Palliat Care 2016; 33 691–702.
| Informal caregivers of palliative oncohematologic patients: the invisible guests: an exhaustive review of the literature available.Crossref | GoogleScholarGoogle Scholar | 25907184PubMed |
[11] Hegney D, Pearce S, Rogers-Clark C, Martin-Mcdonald K, Buikstra E. Close, but still too far. The experience of Australian people with cancer commuting from a regional to a capital city for radiotherapy treatment. Eur J Cancer Care 2005; 14 75–82.
| Close, but still too far. The experience of Australian people with cancer commuting from a regional to a capital city for radiotherapy treatment.Crossref | GoogleScholarGoogle Scholar |
[12] Gordon LG, Ferguson M, Chambers SK, Dunn J. Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. 2009. Available at: https://research-repository.griffith.edu.au/bitstream/handle/10072/30747/62819_1.pdf?sequence=1&isAllowed=y [verified 10 October 2020].
[13] Lentz R, Benson AB, Kircher S. Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol 2019; 120 85–92.
| Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies.Crossref | GoogleScholarGoogle Scholar | 30650186PubMed |
[14] Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient 2017; 10 295–309.
| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay.Crossref | GoogleScholarGoogle Scholar | 27798816PubMed |
[15] Department of Health. Quarterly Medicare statistics 2019. Canberra: Australian Government; 2019.
[16] Cancer Council Western Australia. Annual review highlights 2016–2017. 2017. Available at: https://www.cancerwa.asn.au/resources/2017-11-01-annualreview-webversion.pdf [verified 9 January 2021].
[17] Australian Bureau of Statistics. 1270.0.55.005 – Australian Statistical Geography Standard (ASGS): Volume 5 – Remoteness Structure, July 2016. 2018. Available at: https://www.abs.gov.au/ausstats/abs@.nsf/mf/1270.0.55.005 [verified 13 May 2020].
[18] National Rural Health Alliance. Improving cancer care for rural Australians: report of the Clinical Oncological Society of Australia and the Medical Oncology Group of Australia. 2009. Available at: https://www.ruralhealth.org.au/10thNRHC/10thnrhc.ruralhealth.org.au/papers/docs/Herron_Lisa_COSA_Report.pdf [verified 9 January 2021].
[19] Paul C, Boyes A, Hall A, Bisquera A, Miller A, O’Brien L. The impact of cancer diagnosis and treatment on employment, income, treatment decisions and financial assistance and their relationship to socioeconomic and disease factors. Support. Care Cancer 2016; 24 4739–46.
| The impact of cancer diagnosis and treatment on employment, income, treatment decisions and financial assistance and their relationship to socioeconomic and disease factors.Crossref | GoogleScholarGoogle Scholar | 27364149PubMed |
[20] Slavova‐Azmanova NS, Newton JC, Saunders CM. Marked variation in out-of-pocket costs for cancer care in Western Australia. Med J Aust 2020; 212 525–6.
| Marked variation in out-of-pocket costs for cancer care in Western Australia.Crossref | GoogleScholarGoogle Scholar | 32311092PubMed |
[21] World Health Organization (WHO). Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: WHO, 2010.
[22] Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology 2007; 16 1130–9.
| Exploring the economic impact of breast cancers during the 18 months following diagnosis.Crossref | GoogleScholarGoogle Scholar | 17345557PubMed |
[23] Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19 3219–36.
| Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.Crossref | GoogleScholarGoogle Scholar | 11113956PubMed |
[24] Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320 1197–1200.
| How should cost data in pragmatic randomised trials be analysed?Crossref | GoogleScholarGoogle Scholar | 10784550PubMed |
[25] Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ Rev 2015; 5 11
| Statistical models for the analysis of skewed healthcare cost data: a simulation study.Crossref | GoogleScholarGoogle Scholar | 26029491PubMed |
[26] Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ 2011; 20 897–916.
| Review of statistical methods for analysing healthcare resources and costs.Crossref | GoogleScholarGoogle Scholar | 20799344PubMed |
[27] Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001; 20 461–94.
| Estimating log models: to transform or not to transform?Crossref | GoogleScholarGoogle Scholar | 11469231PubMed |
[28] Bates N, Callander E, Lindsay D, Watt K. CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients. Health Econ Rev 2018; 8 28
| CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients.Crossref | GoogleScholarGoogle Scholar | 30382489PubMed |
[29] Hua X, Erreygers G, Chalmers J, Laba TL, Clarke P. Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: an example using Medicare data from Australia. Health Policy 2017; 121 426–33.
| Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: an example using Medicare data from Australia.Crossref | GoogleScholarGoogle Scholar | 28237388PubMed |
[30] Australian Institute of Health and Welfare (AIHW). Patients’ out-of-pocket spending on Medicare services 2016–17, vol. 2018. Canberra: AIHW; 2018.
[31] Johar M, Mu C, Van Gool K, Wong CY. Bleeding hearts, profiteers, or both: specialist physician fees in an unregulated market. Health Econ 2017; 26 528–35.
| Bleeding hearts, profiteers, or both: specialist physician fees in an unregulated market.Crossref | GoogleScholarGoogle Scholar | 26913491PubMed |
[32] Slavova-Azmanova N, Newton JC, Hohnen H, Johnson CE, Saunders C. How communication between cancer patients and their specialists affect the quality and cost of cancer care. Support Care Cancer 2019; 27 4575–85.
| How communication between cancer patients and their specialists affect the quality and cost of cancer care.Crossref | GoogleScholarGoogle Scholar | 30927112PubMed |
[33] Newton JC, Hohnen H, Johnson CE, Ives A, McKiernan S, Platt V, Saunders C, Slavova-Azmanova N. ‘…If I don't have that sort of money again, what happens?': adapting a qualitative model to conceptualise the consequences of out-of-pocket expenses for cancer patients in mixed health systems. Aust Health Rev 2020; 44 355–64.
| ‘…If I don't have that sort of money again, what happens?': adapting a qualitative model to conceptualise the consequences of out-of-pocket expenses for cancer patients in mixed health systems.Crossref | GoogleScholarGoogle Scholar | 31964474PubMed |
[34] Deliotte Access Economics. Financial impacts of breast cancer in Australia. Canberra: Deliotte; 2017.
[35] Department of Health. Report: ministerial advisory committee on out-of-pocket costs. 2018. Available at: https://www.health.gov.au/sites/default/files/ministerial-advisory-committee-on-out-of-pocket-costs-report.pdf [verfified 1 November 2020].
[36] Bates N, Callander E, Lindsay D, Watt K. Patient co-payments for women diagnosed with breast cancer in Australia. Support Care Cancer 2020; 28 2217–27.
| 31435727PubMed |
[37] Australian Medical Association (AMA). New Informed Financial Consent guide launched. AMA Media Centre, 23 July 2019. Available at: https://ama.com.au/media/new-informed-financial-consent-guide-launched [verified 9 January 2021].
[38] Bates N, Callander E, Lindsay D, Watt K. Labour force participation and the cost of lost productivity due to cancer in Australia. BMC Public Health 2018; 18 375
| Labour force participation and the cost of lost productivity due to cancer in Australia.Crossref | GoogleScholarGoogle Scholar | 29621995PubMed |
[39] Sharma DK, Vangaveti VN, Larkins S. Geographical access to radiation therapy in North Queensland: a retrospective analysis of patient travel to radiation therapy before and after the opening of an additional radiotherapy facility. Rural Remote Health 2016; 16 3640
| 26960266PubMed |
[40] Thompson SC, Cheetham S, Baxi S. The enablers, barriers and preferences of accessing radiation therapy facilities in the rural developed world – a systematic review. BMC Cancer 2017; 17 794
| The enablers, barriers and preferences of accessing radiation therapy facilities in the rural developed world – a systematic review.Crossref | GoogleScholarGoogle Scholar | 29179701PubMed |
[41] Waran E. Radiotherapy: the tyranny of distance. Aust J Rural Health 2017; 25 64–5.
| Radiotherapy: the tyranny of distance.Crossref | GoogleScholarGoogle Scholar | 26123116PubMed |
